A biotechnology company dedicated to developing a forward thinking.

Coupled with their broad target applicability, transgenic mice bring an unparalleled probability and efficiency of success to the discovery and development of quality drug candidates. Related StoriesNew Histone Antibody Specificity Database allows researchers to find correct antibodies for biomedical researchNew study offers potential for early intervention to avoid neurodegenerative diseasesAridis expands, accelerates current AR-301 Phase 2a research for treatment of severe pneumonia in the U.S.’Inside our conversations with pharma and biotech businesses, Third Rock repeatedly found out about the need for a new, robust transgenic mouse antibody platform,’ said Cary Pfeffer, M.D., partner at Third Rock Ventures and member of Ablexis’ panel of directors.With the intro of the ATS 3f Aortic Bioprosthesis to the U.S. Marketplace, surgeons have quickly recognized its unique potential for use in much less invasive port gain access to and robot assisted techniques. Balkhy is only the second one of these procedures in the usa to become performed with robotic help, and is another essential step toward offering surgeons and sufferers better choices for the treating structural heart disease without an open sternotomy. Balkhy can be an innovative thought leader in cardiac surgery who’ll continue steadily to drive the development of minimally invasive, cosmetically favorable methods with excellent medical outcomes for his patients,’ stated Michael Dale, President and CEO of ATS Medical. SOURCE ATS Medical, Inc.. Addicts, hackers stealing identifications and more on the web By Dr Ananya Mandal, MD The annual National Identity Crime Symposium is being held this complete week in Brisbane, Australia.